Literature DB >> 10205219

Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation.

J Goulis1, T N Chau, S Jordan, A B Mehta, A Watkinson, K Rolles, A K Burroughs.   

Abstract

BACKGROUND: Thrombocytopenia in cirrhotic patients may be due to deficient production of thrombopoietin. AIMS: To determine the relation between thrombopoietin and thrombocytopenia in cirrhotic patients before and after orthotopic liver transplantation.
METHODS: Thrombopoietin concentrations and platelet counts were measured in 43 cirrhotic patients and 21 normal controls and serially for 14 days after transplantation in 23/43 patients.
RESULTS: 27 of the 43 patients had thrombocytopenia (platelet count less than 120 x 10(9)/l; group 1) whereas 16 patients had normal platelet count (group 2). Thrombopoietin concentrations were lower in group 1 than in group 2 (92.5 (20.3-286.3) v 226.6 (30.1-848.3) pg/ml, p=0.003) and normal controls (92.5 (20.3-286.3) v 158.3 (22.5-232.9) pg/ml, p=0.028). Post-transplantation thrombopoietin concentrations increased with a peak at day 5. The rise was significant in patients with low pretransplantation platelet count (89.1 (21.29-247.6) to 545.1 (66.2-2569) pg/ml; n=16, p=0.001) but not in those with normal platelet count (262.8 (30.1-848.3) to 315.1 (114-954.6) pg/ml; n=7, p=0.47). No correlation was found pretransplantation between spleen volume and platelet count (r=-0.11, p=0.6) or thrombopoietin concentrations (r=-0.04, p=0.8). However, pretransplantation thrombopoietin concentrations correlated with platelet count (r=0.47, p=0.0015), whereas an inverse correlation was found between peak thrombopoietin concentrations and nadir platelet count (r=-0.41 p=0. 049) post-transplantation.
CONCLUSIONS: Inadequate thrombopoietin production may contribute to cirrhotic thrombocytopenia. Thrombopoietin production is restored after liver transplantation leading to the resolution of thrombocytopenia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10205219      PMCID: PMC1727482          DOI: 10.1136/gut.44.5.754

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  25 in total

1.  Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis.

Authors:  S Shimodaira; F Ishida; N Ichikawa; T Tahara; T Kato; H Kodaira; T Ito; E Tanaka; T Sodeyama; K Kiyosawa; K Kitano
Journal:  Thromb Haemost       Date:  1996-10       Impact factor: 5.249

2.  Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand.

Authors:  F J de Sauvage; P E Hass; S D Spencer; B E Malloy; A L Gurney; S A Spencer; W C Darbonne; W J Henzel; S C Wong; W J Kuang
Journal:  Nature       Date:  1994-06-16       Impact factor: 49.962

3.  Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice.

Authors:  A Grossmann; J Lenox; H P Ren; J M Humes; J W Forstrom; K Kaushansky; K H Sprugel
Journal:  Exp Hematol       Date:  1996-08       Impact factor: 3.084

4.  Circulating thrombopoietin concentrations in thrombocytopenic patients, including cancer patients following chemotherapy, with or without peripheral blood progenitor cell transplantation.

Authors:  Y G Meng; T G Martin; M L Peterson; M A Shuman; R L Cohen; W L Wong
Journal:  Br J Haematol       Date:  1996-12       Impact factor: 6.998

5.  The hematologic consequences of transjugular intrahepatic portosystemic shunts.

Authors:  A J Sanyal; A M Freedman; P P Purdum; M L Shiffman; V A Luketic
Journal:  Hepatology       Date:  1996-01       Impact factor: 17.425

6.  Role of the donor liver in the origin of platelet disorders and hyperfibrinolysis in liver transplantation.

Authors:  R J Porte; E Blauw; E A Knot; M P de Maat; C de Ruiter; C Minke Bakker; O T Terpstra
Journal:  J Hepatol       Date:  1994-10       Impact factor: 25.083

7.  Thrombocytopenia post liver transplantation. Correlations with pre-operative platelet count, blood transfusion requirements, allograft function and outcome.

Authors:  G W McCaughan; R Herkes; B Powers; K Rickard; N D Gallagher; J F Thompson; A G Sheil
Journal:  J Hepatol       Date:  1992-09       Impact factor: 25.083

8.  Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients.

Authors:  O A Alvarez; G A Lopera; V Patel; C E Encarnacion; J C Palmaz; M Lee
Journal:  Am J Gastroenterol       Date:  1996-01       Impact factor: 10.864

9.  Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia.

Authors:  J L Nichol; M M Hokom; A Hornkohl; W P Sheridan; H Ohashi; T Kato; Y S Li; T D Bartley; E Choi; J Bogenberger
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

10.  Production of thrombopoietin (TPO) by rat hepatocytes and hepatoma cell lines.

Authors:  Y Shimada; T Kato; K Ogami; K Horie; A Kokubo; Y Kudo; E Maeda; Y Sohma; H Akahori; K Kawamura
Journal:  Exp Hematol       Date:  1995-12       Impact factor: 3.084

View more
  22 in total

Review 1.  New insights into the coagulopathy of liver disease and liver transplantation.

Authors:  M Senzolo; P Burra; E Cholongitas; A-K Burroughs
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

2.  Synergism between hepatocellular injury and shunting in portosystemic encephalopathy (PSE): case report of acute brittle TIPS-induced PSE.

Authors:  Gil Weitzman; Neil J Schamberg; Gerond Lake-Bakaar
Journal:  Dig Dis Sci       Date:  2007-07-20       Impact factor: 3.199

3.  Plasma thrombopoietin in patients with cavernous transformation of the portal vein.

Authors:  Hakan Göker; Türker Egesel; Sema Karakuş; Ibrahim C Haznedaroglu; Sule Apraş; Yahya Büyükaşic; Nilgün Sayinalp; Osman I Ozcebe; Semra Dundar; Serafettin Kirazli; Yusuf Bayraktar
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

4.  Dysfunction in Patients With Small-for-Size Grafts After Living Donor Liver Transplantation.

Authors:  Shozo Mori; Min-Su Park; Hyeyoung Kim; Youngrok Choi; Geun Hong; Nam-Joon Yi; Kwang-Woong Lee; Kyung-Suk Suh
Journal:  Int Surg       Date:  2015-03

5.  Effect of thrombopoietin on platelet counts and liver regeneration after partial hepatectomy in a rat model.

Authors:  Rinshun Shimabukuro; Hirofumi Kawanaka; Morimasa Tomikawa; Tomohiko Akahoshi; Kozo Konishi; Daisuke Yoshida; Go Anegawa; Hideo Uehara; Naotaka Hashimoto; Makoto Hashizume; Yoshihiko Maehara
Journal:  Surg Today       Date:  2009-12-08       Impact factor: 2.549

6.  Radiofrequency ablation for hypersplenism in patients with liver cirrhosis: a pilot study.

Authors:  Quanda Liu; Kuansheng Ma; Zhenping He; Jiahong Dong; Xin Hua; Xuequan Huang; Liang Qiao
Journal:  J Gastrointest Surg       Date:  2005 May-Jun       Impact factor: 3.452

Review 7.  [Perioperative anesthesia management of extended partial liver resection. Pathophysiology of hepatic diseases and functional signs of hepatic failure].

Authors:  S Herz; G Puhl; C Spies; D Jörres; P Neuhaus; C von Heymann
Journal:  Anaesthesist       Date:  2011-02       Impact factor: 1.041

8.  Right liver lobe/albumin ratio: contribution to non-invasive assessment of portal hypertension.

Authors:  Tamara Alempijevic; Vladislava Bulat; Srdjan Djuranovic; Nada Kovacevic; Rada Jesic; Dragan Tomic; Slobodan Krstic; Miodrag Krstic
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

Review 9.  Thrombin activation and liver inflammation in advanced hepatitis C virus infection.

Authors:  Emilio González-Reimers; Geraldine Quintero-Platt; Candelaria Martín-González; Onán Pérez-Hernández; Lucía Romero-Acevedo; Francisco Santolaria-Fernández
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

10.  Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma.

Authors:  Shinn-Jang Hwang; Jiing-Chyuan Luo; Chung-Pin Li; Cheng-Wei Chu; Jaw-Ching Wu; Chiung-Ru Lai; Jen-Huei Chiang; Gar-Yang Chau; Wing-Yiu Lui; Chun-Chung Lee; Full-Young Chang; Shou-Dong Lee
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.